(CTKB) Cytek Biosciences - Performance -39.4% in 12m
CTKB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-78.94%
#167 in Peer-Group
Rel. Strength
14.14%
#6367 in Stock-Universe
Total Return 12m
-39.39%
#148 in Peer-Group
Total Return 5y
-81.88%
#145 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 370 |
| High / Low | USD |
|---|---|
| 52 Week High | 7.40 USD |
| 52 Week Low | 2.42 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 86.11 |
| Buy/Sell Signal +-5 | -2.08 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CTKB (-39.4%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Health Care Equipment
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| STE NYSE STERIS |
-0.53% | 11% | 63.3% | 38.8 | 24 | 1.95 | 64.0% | 69.1% |
| ITGR NYSE Integer Holdings |
4.49% | 6.78% | 70.1% | 55.3 | 21.3 | 0.93 | 39.6% | -28.7% |
| RMD NYSE ResMed |
5.72% | 39.3% | 39.8% | 28.2 | 24.1 | 1.49 | 88.9% | 16.9% |
| SHL XETRA Siemens Healthineers |
2.77% | -11.1% | 21.3% | 24.7 | 16.7 | 1.52 | 12.9% | 7.65% |
| DEMANT CO Demant |
5.01% | -12.5% | 46% | 20.1 | 19.8 | 0.95 | -3.70% | 7% |
| GMED NYSE Globus Medical |
0.1% | -13.1% | 20.1% | 43.9 | 18.7 | 1.7 | -16.6% | 7.79% |
| SOON SW Sonova H |
-5.35% | -14.2% | 30.5% | 26.6 | 19.5 | 1.76 | 35.7% | 36.3% |
| DRW3 XETRA Drägerwerk & Co. KGaA |
-0.15% | 39.1% | -3.27% | 11.2 | - | 1.46 | -14.1% | -19.6% |
Performance Comparison: CTKB vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CTKB
| Total Return (including Dividends) | CTKB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 20.14% | 2.04% | 4.55% |
| 3 Months | -15.21% | -7.24% | 10.78% |
| 12 Months | -39.39% | -5.41% | 14.71% |
| 5 Years | -81.88% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | CTKB | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 26.1% | 34.5% | 79.2% |
| 3 Months | -59.7% | -46.5% | 92.9% |
| 12 Months | -68.2% | -71.8% | 44.2% |
| 5 Years | -92.3% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th91.00 | 17.73% | 14.91% |
| 3 Month | %th27.00 | -8.59% | -23.46% |
| 12 Month | %th26.50 | -35.92% | -47.17% |
| 5 Years | %th32.00 | -83.41% | -87.81% |
FAQs
Does Cytek Biosciences (CTKB) outperform the market?
No,
over the last 12 months CTKB made -39.39%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months CTKB made -15.21%, while XLV made -7.24%.
Performance Comparison CTKB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CTKB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6% | 15.6% | -53.7% | -54% |
| US NASDAQ 100 | QQQ | 5.2% | 14.6% | -55.8% | -55% |
| German DAX 40 | DAX | 6.2% | 20.1% | -66.6% | -69% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.4% | 16% | -51.7% | -57% |
| Hongkong Hang Seng | HSI | 6.4% | 14.4% | -69.4% | -75% |
| India NIFTY 50 | INDA | 6.5% | 18.1% | -53.4% | -39% |
| Brasil Bovespa | EWZ | 4.7% | 12.4% | -78.2% | -53% |
CTKB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.5% | 13.4% | -60.3% | -68% |
| Consumer Discretionary | XLY | 7.6% | 18.5% | -45% | -59% |
| Consumer Staples | XLP | 9.5% | 21.8% | -51.9% | -49% |
| Energy | XLE | 10.4% | 16.6% | -48.2% | -35% |
| Financial | XLF | 5.9% | 17.1% | -56.7% | -68% |
| Health Care | XLV | 7% | 18.1% | -46.4% | -34% |
| Industrial | XLI | 6.4% | 16.4% | -60.3% | -64% |
| Materials | XLB | 8% | 18.5% | -53% | -42% |
| Real Estate | XLRE | 10.5% | 20.1% | -51% | -52% |
| Technology | XLK | 4.7% | 11.3% | -56.9% | -51% |
| Utilities | XLU | 8.5% | 20.1% | -57% | -64% |
| Aerospace & Defense | XAR | 4.1% | 10.3% | -75.1% | -92% |
| Biotech | XBI | 8.2% | 18.1% | -39.7% | -29% |
| Homebuilder | XHB | 7.8% | 14.1% | -42.4% | -40% |
| Retail | XRT | 9.1% | 18.7% | -44.9% | -46% |
CTKB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 13.3% | 15.0% | -44.4% | -29% |
| Natural Gas | UNG | 18.2% | 29.6% | -38.5% | -32% |
| Gold | GLD | 11% | 22.3% | -73.5% | -81% |
| Silver | SLV | 9.4% | 16.3% | -72.2% | -62% |
| Copper | CPER | 5.7% | 16% | -73.4% | -55% |
CTKB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.3% | 16.5% | -50.5% | -41% |
| iShares High Yield Corp. Bond | HYG | 8.1% | 18.3% | -52.6% | -50% |